On September 22, 2026, Bird&Be announced that it raised US$13 million in a Series A financing co-led by BDC Capital’s Thrive Fund and BFG Partners, with participation from BAM Ventures, Founder Collective, Rejuvenation Ventures and HSR Ventures. Bird&Be plans on utilizing the financing towards product development and expanding the retail distribution of its reproductive health products.
Bird&Be is a Toronto-based reproductive health company that provides fertility and wellness supplements and at-home testing products for men and women. Its products support customers at different stages of their reproductive health journey, including conception, pregnancy and postpartum recovery.
Osler, Hoskin & Harcourt LLP advised Bird&Be with a team consisting of David Jamieson and Daniel Tyberg (Emerging and High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Associate, Emerging and High Growth Companies, Toronto